Rubis SCA (RUI):企業の財務・戦略的SWOT分析

◆英語タイトル:Rubis SCA (RUI) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2498
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Rubis SCA (RUI) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Rubis SCA (Rubis) is an independent downstream company that carries out the storage, distribution and trading of bulk petroleum and chemical products. Its product portfolio includes fuel oil, liquefied petroleum gas (LPG), gasoline, diesel, home heating oil, chemical products, edible oils, molasses and liquid fertilizers. The company Builds, maintains and manages bulk storage facilities in maritime, river docking areas and near industrial sites. Rubis operates bulk liquid storage facilities in France, the Netherlands, Belgium and Turkey. It also offers infrastructure, transportation, supply and services, supporting the development of downstream distribution and marketing business. The company has operational presence across Europe, Africa and the Caribbean. Rubis is headquartered in Paris, France.

Rubis SCA Key Recent Developments

Jul 03,2017: Regulator Says No To Barbados Government’s Plan To Sell Oil Terminal
May 09,2017: Rubis: First-quarter Revenue: €896 Million (+22%) – Good Start To Year, With Volume Growth Of 8%

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Rubis SCA – Key Facts 6
Rubis SCA – Key Employees 7
Rubis SCA – Key Operational Employees 8
Rubis SCA – Major Products and Services 9
Rubis SCA – History 10
Rubis SCA – Company Statement 12
Rubis SCA – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 15
Company Overview 15
Rubis SCA – Business Description 16
Business Segment: Rubis Energie 16
Overview 16
Performance 16
Key Stats 16
Business Segment: Rubis Support and Services 16
Overview 16
Performance 17
Business Segment: Rubis Terminal 17
Overview 17
Performance 17
Key Stats 17
Geographical Segment: Africa 17
Performance 17
Geographical Segment: Caribbean 17
Performance 17
Geographical Segment: Europe 18
Performance 18
Rubis SCA – Corporate Strategy 19
Rubis SCA – SWOT Analysis 20
SWOT Analysis – Overview 20
Rubis SCA – Strengths 20
Rubis SCA – Weaknesses 21
Rubis SCA – Opportunities 22
Rubis SCA – Threats 23
Rubis SCA – Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios – Capital Market Ratios 25
Financial Ratios – Annual Ratios 26
Performance Chart 29
Financial Performance 29
Financial Ratios – Interim Ratios 30
Financial Ratios – Ratio Charts 31
Section 4 – Company’s Oil & Gas Financial Deals and Alliances 32
Rubis SCA, Oil & Gas, Deals By Year, 2012 to YTD 2018 32
Rubis SCA, Oil & Gas, Deals By Type, 2012 to YTD 2018 33
Rubis SCA, Recent Deals Summary 34
Section 5 – Company’s Recent Developments 35
May 09, 2017: Rubis: First-quarter Revenue: €896 Million (+22%) – Good Start To Year, With Volume Growth Of 8% 35
Section 6 – Appendix 37
Methodology 37
Ratio Definitions 37
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Rubis SCA, Key Facts 6
Rubis SCA, Key Employees 7
Rubis SCA, Key Operational Employees 8
Rubis SCA, Major Products and Services 9
Rubis SCA, History 10
Rubis SCA, Subsidiaries 13
Rubis SCA, Key Competitors 24
Rubis SCA, Ratios based on current share price 25
Rubis SCA, Annual Ratios 26
Rubis SCA, Annual Ratios (Cont...1) 27
Rubis SCA, Annual Ratios (Cont...2) 28
Rubis SCA, Interim Ratios 30
Rubis SCA, Oil & Gas, Deals By Year, 2012 to YTD 2018 32
Rubis SCA, Oil & Gas, Deals By Type, 2012 to YTD 2018 33
Rubis SCA, Recent Deals Summary 34
Currency Codes 37
Units 37
Capital Market Ratios 37
Equity Ratios 38
Profitability Ratios 38
Cost Ratios 39
Liquidity Ratios 40
Leverage Ratios 40
Efficiency Ratios 40

List of Figures
Rubis SCA, Performance Chart (2013 - 2017) 29
Rubis SCA, Ratio Charts 31
Rubis SCA, Oil & Gas, Deals By Year, 2012 to YTD 2018 32
Rubis SCA, Oil & Gas, Deals by Type, 2012 to YTD 2018 33

★海外企業調査レポート[Rubis SCA (RUI):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Karur Vysya Bank Ltd:企業の戦略・SWOT・財務情報
    Karur Vysya Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary Karur Vysya Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • GEN energija, d.o.o.:企業の戦略的SWOT分析
    GEN energija, d.o.o. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Adamis Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向
    Adamis Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Adamis Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • HUYA Bioscience International LLC-製薬・医療分野:企業M&A・提携分析
    Summary HUYA Bioscience International LLC (HUYA) is a developer of early and late stage drug candidates. The company’s pipeline products comprise HBI-8000, HBI-3000, and HBI-3802. Its HBI-8000 is a novel oral inhibitor of histone deacetylases; HBI-3000 is a channel blocker for the treatment of arrhy …
  • G1 Therapeutics Inc (GTHX):製薬・医療:M&Aディール及び事業提携情報
    Summary G1 Therapeutics Inc (G1 Therapeutics), formerly G Zero Therapeutics Inc, is a clinical stage biopharmaceutical company that discovers, develops and commercializes therapeutics for the treatment of cancer. The company’s pipeline products include trilaciclib (G1T28), a CDK4/6 inhibitor to pres …
  • Senhwa Biosciences Inc (6492):製薬・医療:M&Aディール及び事業提携情報
    Summary Senhwa Biosciences Inc (Senhwa) is a clinical stage drug development company that develops next generation DNA damage response drugs for the treatment of cancer. The company’s pipeline products include CX-5461 and CX-4945. Its CX-5461, a G4-stabilizing compound, is a Pol I inhibitor that tri …
  • Waters Corporation:企業の戦略・SWOT・財務情報
    Waters Corporation - Strategy, SWOT and Corporate Finance Report Summary Waters Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tanzania Electric Supply Co Ltd:発電所・企業SWOT分析
    Tanzania Electric Supply Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on k …
  • China Petroleum & Chemical Corporation (Sinopec):戦略・SWOT・企業財務分析
    China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corporation (Sinopec) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • AEON Credit Service (Asia) Co., Ltd.:企業の戦略・SWOT・財務情報
    AEON Credit Service (Asia) Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary AEON Credit Service (Asia) Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Laboratorio Teuto Brasileiro SA-製薬・医療分野:企業M&A・提携分析
    Summary Laboratorio Teuto Brasileiro SA (Teuto), a subsidiary of Pfizer Inc is a drug company that develops, manufactures, and markets generic and over the counter products. The company’s products include aerodini aerosol salbutamol sulphate, afopic folic acid, albentel albendazole, acetato de dexam …
  • 1-800-FLOWERS.COM Inc (FLWS):企業の財務・戦略的SWOT分析
    1-800-FLOWERS.COM Inc (FLWS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Grupo Elektra, S.A. de C.V.:企業の戦略・SWOT・財務分析
    Grupo Elektra, S.A. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Grupo Elektra, S.A. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Connecticut Municipal Electric Energy Cooperative:企業の戦略的SWOT分析
    Connecticut Municipal Electric Energy Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competi …
  • Integrated BioTherapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Integrated BioTherapeutics Inc (IBT) is a biotechnology company that discovers novel vaccines and therapeutics for infectious diseases. The company's products include polyclonal and monoclonal antibodies raised against emerging pathogens, pan-filovirus antibody candidates, vaccines and thera …
  • Vifor Pharma AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Vifor Pharma AG (Vifor Pharma) a subsidiary of Galenica Ltd is a healthcare service provider that discovers, develops, manufactures, and commercializes prescription and over the counter pharmaceutical products for the treatment of iron replacement therapy. The company offers products for tre …
  • Cytokinetics Inc (CYTK):製薬・医療:M&Aディール及び事業提携情報
    Summary Cytokinetics Inc (Cytokinetics) is a late stage biopharmaceutical company, which discovers, develops, and commercializes muscle activators for the treatment of diseases associated with reduced muscle performance. The company’s pipeline encompasses omecamtiv mecarbil, a novel cardiac myosin a …
  • Eutelsat Communications Group:企業の戦略・SWOT・財務分析
    Eutelsat Communications Group - Strategy, SWOT and Corporate Finance Report Summary Eutelsat Communications Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • The Saudi Arabian Monetary Agency:企業の戦略的SWOT分析
    The Saudi Arabian Monetary Agency - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Nachi-Fujikoshi Corp.
    Nachi-Fujikoshi Corp. - Strategy, SWOT and Corporate Finance Report Summary Nachi-Fujikoshi Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆